Lymphoma Mabs rivalry continues.
Webber
D
D
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D001709:Biotechnology; D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval; D006801:Humans; D018796:Immunoconjugates / Q000009:adverse effects / Q000627:therapeutic use; D016393:Lymphoma, B-Cell / Q000628:therapy*; D012449:Safety; D014481:United States
D000911:Antibodies, Monoclonal; D018796:Immunoconjugates